Select Sidearea
Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.
hello@youremail.com
+1234567890
+1234567890
In 2018, co-founders Esra Erdal & Bugraer Aslan crossed paths to discover that they have complimentary vision of developing state of the art iPSC derived organoid systems to test drugs in better modeled systems and improve treatment efficieny in Turkey and expand this globally. After bringing together a team of multi-disciplinary experts from engineering, genetics, molecular biology and commercialisation they were able to proove their concept and receive several local funds. They published globally recognized articles which brought them significant interest on their 3D hepatocyte models by global players. In 2020, they launched Organo-ID as a predictive diagnostic company.
Our mission is to enable personalized research and treatments through high-quality science and multi-disciplinary teams.
Our vision is to deliver personalized therapies through cutting-edge science and partnerships across the globe to provide patients with treatments with positive outcomes.
Dr. Bugraer Aslan is the co-founder and CEO of Organo-ID. Bugraer has a 20+ pharma and business development experience specalizing in oncology and rare disease areas. Prior to starting up Bugraer led the global development strategy of Hasbiotech. Before Hasbiotech, he worked at Bayer as a regional manager and medical science liaison lead. He also held multiple other industry and academic positions. Dr. Aslan, studied biology and completed his PhD in Biotechnology.
Prof. Dr. Esra Erdal is the co-founder and Chief Scientific Officer at Organo-ID leading the scientific strategy and development. Prof. Erdal is a research group leader at Izmir Biomedicine and Genome Center leading the research on Stem Cell and Organoid Technologies Lab. and working as a Principle Investigator at Department of Medical Biology in Faculty of Medicine at Dokuz Eylul University. She specializes on cancer biology and disease modeling via organoid technologies with 44 research publications in the peer-reviewed journals indexing SCI and/or SCIE (https://orcid.org/0000-0001-7264-0574) (h-index:19). Prior to starting up Organo-ID, Prof. Erdal was a visiting research scientist at organizations like Duke University, INSERM and Osaka University. She graduated from Department of Biology at Middle East Technical University and completed her MsC in Biotechnology at the same University. She then finished her PhD in Molecular Biology and Genetics at Bilkent University. Furthermore, she received some awards including “L’OREAL Award for Women in Science in Turkey” and “Dr. Nejat F. Eczacıbaşı Research Support Award”.
